Data as of 2:20pm ET
| +0.19 / +3.12%|
The 6 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 23.50, with a high estimate of 26.00 and a low estimate of 20.00. The median estimate represents a +274.80% increase from the last price of 6.27.
The current consensus among 7 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.